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ABSTRACT 
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at Virginia Commonwealth University. 
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Thesis Director: Diomedes E. Logothetis, Ph.D. 
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 G protein-coupled receptors (GPCRs) are seven-transmembrane domain receptors that 
sense extracellular signal and activate intracellular signaling pathways. Metabotropic glutamate 
receptor 2 (mGluR2) is one of the GPCRs coupled to Gi/o proteins whose Gβγ subunits stimulate 
G protein-gated inwardly rectifying K+ channels (GIRKs). Previous experiments demonstrated 
that in planar lipid bilayer both active forms of G proteins [Gα (GTPγS-stimulated) and Gβγ 
subunits] were required to activate GIRK channels in the absence of the receptor, but 
surprisingly, the Gβγ subunit alone could activate GIRK channel in the presence of GPCR. 
Currently, it is not clear whether GPCRs play a role beyond catalyzing the dissociation of Gα 
and Gβγ subunits in the presence of extracellular agonist and intracellular GTP. Here we 
compare the G protein-stimulated GIRK currents in the presence and absence of mGluR2 by 
performing whole-cell patch clamp recordings on two types of cells: a HEK293 cell line stably 
expressing GIRK channels (HEK/GIRK) and HEK/GIRK cells with mGluR2 expressed 
transiently. Our experiments revealed that mGluR2 affects the behavior of G proteins even in the 
absence of the agonist. We show that intracellular application of GTP activated GIRK currents, 
and the GTP-induced GIRK currents became greater in the presence mGluR2. We also show that 
desensitization kinetics of the GTP-stimulated GIRK currents became greater and faster in the 
presence of mGluR2. 
 
 
  
 
 
 
 
 
 
 
 
INTRODUCTION 
 
G protein-coupled receptors (GPCRs) are a large family of transmembrane receptors that 
sense extracellular signals and transmit them to various intracellular downstream effectors. 
GPCRs are biological molecules that have been vigorously studied due to their involvement in 
many diseases (Filmore, 2004). In fact, GPCR is the target of approximately 30% of all modern 
medicinal drugs (Overington et al., 2006). The mechanism by which GPCRs signal to 
downstream effector state that when an agonist binds to an extracellular receptor binding site 
specific G protein signaling pathways are activated inside the cell (Oldham and Hamm, 2008). 
The first event that occurs upon activation of G protein signaling is that the G protein 
heterotrimer exchanges its bound GDP for a GTP. The heterotrimer can then dissociate into its 
component Gα and Gβγ subunits and activate its downstream effectors. There are various 
subtypes of G proteins in the cell (e.g. Gi/o, Gq/11 and Gs) and each of them are coupled to their 
their specific subtypes of GPCRs (Wetschureck and Offermann, 2005).  
One of the downstream effectors of GPCRs is G protein-gated inwardly rectifying 
potassium channels (GIRKs). GIRK channels are broadly distributed in the central nervous 
system and in the heart, controlling heart rate and neuronal excitability (Kobayash, et al., 1995; 
 Karschin, et al., 1996; Chen, et al., 1997; Krapiyinsky, et al., 1995). Four mammalian isoforms 
comprise the GIRK subfamily: GIRK1-GIRK4 (Kubo et al., 1993; Dascal et al., 1993; Lesage et 
al., 1994; Kaprivinsky et al., 1995). GIRK1 channels function only as heteromers in association 
with one of the other subunits.  For example, Some GIRK channels in cardiac tissue exist as 
heterotetramers composed of two GIRK1 and two GIRK4 subunits (Kaprivinsky et al., 1995). 
The other subunits (GIRK2-GIRK4) can function both as homotetramers and heterotetramers 
and are found in either form in several tissues. GIRK channels are inwardly-rectifying, which 
means they pass current (positive current) more easily in the inward direction (into the cell). 
Upon activation of Gi/o signaling pathway, Giβγ subunit directly interacts with GIRK channels, 
and this interaction causes the channel to be permeable to potassium ions, resulting in 
hyperpolarization of the cell (Logothetis et al. 1987).  
Besides Gi/o signaling, GIRK channels are also activated via a G-protein-independent 
mechanism, which requires MgATP modification of channel activity (prolongation of the mean 
open time) for subsequent gating by intracellular sodium ions (Sui, et al., 1996). Hydrolysis of 
ATP sensitizes the channel to intracellular sodium ions and G protein gating through formation 
of Phosphatidylinositol-4,5-bisphosphate (PIP2) from Phosphatidylinositol (PI), which controls 
both Gβγ and Na+ gating (Huang, et al., 1998; Sui, et al., 1998). The mechanism of Na+-induced 
GIRK activation is operative during intracellular Na+ accumulation, as with block of the Na+/K+ 
pump, and is likely to be involved in the electrophysiologic effects of cardiac glycosides, drugs 
widely used in heart failure or for improvement of the inotropic state of heart (Sui, et al., 1996). 
Gi-mediated GIRK activation is regulated by intracellular PIP2 level and GTPase activity 
(Kobrinsky, et al., 2000; Breitwieser and Szabo, 1998). Gq signaling activates phospholipase C, 
a class of enzymes that cleaves PIP2 into diacyl glycerol (DAG) and inositol 1,4,5-triphosphate 
(IP3). Previous studies demonstrated that PLC-mediated PIP2 depletion in COS-1 cells results in 
rapidly desensitizing GIRK currents (Kobrinsky, et al., 2000). Rapid GTPase activity of G 
proteins also causes the stimulated GIRK currents to rapidly desensitize (Breitwieser and Szabo, 
1998). Once Gα-bound GTP is hydrolyzed into GDP, the Gα subunit re-associates with the Gβγ 
subunit, inhibiting the interaction of Gβγ with GIRK channel. Earlier studies revealed that 
coexpression of certain regulators of G protein signaling (RGS) proteins that accelerate G 
 protein’s GTPase activity, fully reconstitutes the GIRK activation and deactivation kinetics 
observed in native cells (Doupnik et al., 1997; Saitoh et al., 1997). 
The metabotropic glutamate receptors (mGluRs) are members of the class 3 G protein-
coupled receptor family, which includes the calcium sensing receptor and the GABAB receptor, 
among others (Conn and Pin, 1997). There are eight known mammalian mGluR genes (mGluR1-
8), which play diverse roles in the nervous system, including the modulating of synaptic 
transmission from both pre- and postsynaptic locations and regulation of synaptic plasticity. In 
addition, mGluRs also play a role in mediating sensory transduction (Bortolotto et al., 1994; 
Conn and Pin 1997; Wilsch et al., 1998). mGluRs have been divided into three groups based on 
sequence homology, sensitivity to pharmacological agents, and G protein –coupling specificity 
(De Blasi et al., 2001). Metabotropic Glutamate receptor 2 (mGluR2), the receptor employed in 
our study, is a member of group II that is known to couple exclusively to the Gi/o signaling 
pathway (Tanabe et al., 1992). It is considered a new target for potential anti-psychotic drugs and 
recently received attention in preclinical and clinical studies (Krystal et al., 2003). In our study, 
since the activity of GIRK is stimulated in response to the activation of the Gi/o signaling 
pathway, we measured GIRK current via whole-cell patch clamp recording to monitor the degree 
of mGluR2-mediated stimulation of  Gi/o signaling. 
Although G protein signaling, starting from the binding of receptor’s ligands and ending 
with the induction of ion current, has long been studied by many researchers, we still lack 
structures of complexes revealing detailed interactions among GPCRs, G proteins and ion 
channels. Thus, the interactions among these components leading to modulation of channel 
function are not well understood. In 1987 Logothetis et. al. first demonstrated that the Gβγ 
subunits directly interact and activate GIRK channels (Logothetis et. Al., 1987). Increases in 
GIRK activity were observed when purified Gβγ subunits were applied to the intracellular 
surface of inside-out patches of chick embryo atrial cells. Excised membrane patches contained 
GPCRs and G proteins as well as GIRK channels, but it was not investigated whether GPCRs 
played a role beyond catalyzing the dissociation of Gα and Gβγ subunits in the presence of 
extracellular agonist and intracellular GTP. A recent study from our laboratory published by 
Leal-pinto et al. demonstrated that in planar lipid bilayer experiments both active forms of G 
proteins [Gα (GTPγS-stimulated) and Gβγ subunits] were required to activate GIRK channels in 
 the absence of the receptor (Leal-pinto et al., 2010). Moreover, unpublished data (Leal-Pinto and 
colleagues) collected by our group indicates that the Gβγ subunit alone can only activate GIRK 
channel only in the presence of GPCR. Overall, these observations suggest a new role for 
GPCRs in the Gβγ-mediated GIRK activation. 
In this study we tested whether the presence of GPCRs affects GIRK activation in a 
mammalian system. We demonstrated that the magnitude of GIRK stimulated currents and 
desensitization kinetics change due to the presence of mGluR2. Data were collected mainly by 
performing whole-cell patch clamp recordings. To differentiate between responses in the 
presence of mGluR2 from those in the absence of mGluR2, we employed two types of cells, a 
HEK/GIRK stable cell line and a HEK/GIRK with mGluR2 expressed transiently.  In addition, 
we used different stimulators, e.g. GTPγS, GTP and Glutamate, to distinguish between direct G 
protein stimulation from GPCR-influenced G protein activation. 
  
 
 
MATERIALS AND METHODS 
 
 
A) HEK-293 cells stably expressing GIRK1+GIRK4. 
 
I assisted Dr. Lia Baki in stably expressing Kir3.1 (GIRK1) and Kir3.4 (GIRK4) in HEK-
293 cells. To express the Kir3.1 and Kir3.4 subunits we used the mammalian bidirectional 
expression vector pBI-CMV1 (Clontech Laboratories, Madison, WI) which allows the 
simultaneous constitutive expression of two proteins of interest, driven by constitutively active, 
minimal human cytomegalovirus promoters, PminCMV1 and PminCMV2, respectively. The 
Kir3.1 subunit was subcloned between BamH1-Not1 of the multiple cloning site MCS 1 
(immediately downstream of PminCMV1) and the Kir3.4 subunit was subcloned between 
EcoRI-BglII of the MCS 2 (immediately downstream of PminCMV2). Subcloning was screened 
by restriction analysis and confirmed by sequencing before transfection into the mammalian cells.  
To allow for selection of stable clones we used the pPUR selection vector (Clontech Laboratories, 
Madison, WI) that confers puromycin resistance to eukaryotic cells.  
 
DNA from the vectors (pPUR and pBI-CMV1 carrying Kir3.1 and Kir3.4) was prepared 
using the EndoFree plasmid Purification kit (QIAGEN,  Hilden, Germany) and a mixture of both 
DNAs at 1:20 :ratio was transfected into HEK-293 cells using Lipofectamine 2000 Reagent 
(Invitrogen, Carlsbad, CA), according to the manufacturer’s instructions. 
 
Screening of the clones was a two-step procedure. At first, all surviving clones were 
screened by Western Immunoblotting as described in C and the GIRK-positive clones were 
subjected to electrophysiological recordings (See D). 
 
  
 
 
B) Cell Culture and Transient Transfection 
 
The HEK293 cell line stably expressing GIRK1/4 (HEK/GIRK cells) was grown in 
Dulbecco’s modified Eagle’s medium (DMEM) (Invitrogen, Carlsbad, CA) supplemented with 
10% fetal bovine serum (FBS) (Atlanta Biologicals, Inc., Lawrenceville, GA). The HEK/GIRK 
cells were transiently transfected with mGluR2. The HEK/GIRK cells were trypsinized and 
suspended in the Opti-MEM (Invitrogen, Carlsbad, CA) + 5% FBS and then plated on a 6-well 
plate one day prior to the transfection. Each wells on the plate contained different concentration 
of cells. On the next day, wells that show 90 to 95% confluency of cells were chosen to be 
transfected. 6µg of mGluR2 DNA and 250µL of Lipofectamine 2000 reagent (Invitrogen, 
Carlsbad, CA) were mixed with 250µL of serum-free Opti-MEM separately in different tubes 
and were left in room temperature for 30 minutes. In the case where two or more wells were to 
be transfected, the amount of DNA, Lipofectamine and serum-free Opti-MEM were multiplied 
by the number of wells. After 30 minutes, the DNA + Opti-MEM were transferred into the tube 
containing the mixture of Lipofectamine and Opti-MEM and gently mixed.  The mixture was 
again left in RT for 30 minutes.  After 30 minutes, 500µL of the mixture was directly pipetted 
into each wells and placed in the incubator. After 24 hours, the medium was replaced with fresh 
Opti-MEM containing 5% FBS.  
 
C) Western Immunoblotting  
 
I assisted Dr. Lia Baki in performing western blot to confirm the expression of GIRK and 
mGluR2 after transfections. Confluent cells, cultured in 60mm dishes, were washed once with 
PBS, and directly lysed on the culture dish by the addition of 300 ml RIPA lysis  buffer (Santa 
Cruz Biotechnology, Santa Cruz, CA), containing Protease inhibitors (Roche Diagnostics, Basel, 
Switzerland).  Lysed cells were scraped from the dish, transferred to microfuge tubes and 
sonicated at 4oC. Lysates were, mixed with 1/3 volume of 4X SDS-PAGE loading buffer and 
boiled for 10min before loading in 4-15% gradient polyacrylamide gels (Biorad, Hercules, CA ). 
  
Proteins were separated according to their electrophoretic mobility by SDS-PAGE 
(Sodium Dodecyl Sulfate Polyacrylamide Gel Electrophoresis) and then transferred to PVDF 
membranes at 100V for one hour. The membranes were washed with T-TBS, blocked for two 
hours in NCS blocking solution and probed overnight at 4oC with the appropriate antibodies. For 
GIRK 1 detection we used the anti Kir3.1 polyclonal antibody H-145 (Santa Cruz Biotechnology, 
Santa Cruz, CA), for N-cadherin detection we used the BD Transduction Laboratories anti N-
cadherin mouse monoclonal antibody (BD Transduction Laboratories, Franklin Lakes, NJ) and 
for detection of the HA-tagged mGluR2 we used 0.5 µg/ml of rat anti-HA antibody 3F10 
(Boehringer Mannheim, Mannheim, Germany). 
 
Following extensive washing with T-TBS (more than 2 hours at room temperature with 
frequent changes) the membranes were probed with the appropriate secondary antibodies (anti-
rabit for GIRK, anti-rat for mGLuR2 and anti-mouse for N-cadherin) for 90 min at room 
temperature, washed in T-TBS (90 min at room temperature with frequent changes) and 
incubated for 5 min in Amersham ECL Plus Chemiluminescence detection reagent (GE 
Healthcare, Waukesha, WI) before being exposed to Autoradiograpy films. 
 
D) Whole-cell patch clamp recordings and measurements 
 
Whole-cell patch clamp recordings were obtained from HEK293 cells that overexpressed 
GIRK1/4 alone or overexpressed GIRK1/4 and mGluR2. Cells that had been plated on 100 mm 
dishes were trypsinized to resuspend them in medium containing DMEM (Invitrogen, Carlsbad, 
CA) and 10% fetal bovine serum (Atlanta Biologicals, Inc., Lawrenceville, GA). The cells were 
aliquoted in 1mL tubes with tops open and were placed in the incubator for 3 hours for recovery.  
After 3 hours, cells were placed on poly-lysined coverslips that fit in the chamber of the patch-
clamp setup. It usually took ~15 minutes for the cells to attach to the coverslips. When cells 
firmly anchored to the coverslip, the medium was replaced by perfusing an “External solution” 
that contained in mM: 140 Potassium gluconate, 2 CaCl2, 5 EGTA/K, 10 Glucose, 10 HEPES-K 
and 1 MgCl2. Electrodes were pulled to a resistance around 1.5~2.5MΩ. The electrodes were 
filled with “Internal solution” that contained in mM: 140 Potassium gluconate, 2 CaCl2, 5 
 EGTA/K, 10 Glucose, 10 HEPES-K, 0.3 MgCl2, 2 NaATP. The internal solution also contained 
different concentrations of GTPγS or GTP as indicated in different recordings. The electrode was 
placed so that it gently touched the exterior of the target cell and negative pressure was applied 
until the electrode sealed on the cell membrane achieving a gigaohm resistance seal. In order to 
establish the whole-cell mode, the membrane surrounded by the tip of electrode was disrupted by 
applying a gentle suction. Only the cells that retained the gigaohm resistance were subjected to 
the whole-cell recordings. A voltage ramp from -100mV to +100mV was applied once every 3 
seconds. Currents corresponding to -95mV were plotted as a function of time to produce time 
course relationships. The inward potassium currents were blocked by placing 3mM BaCl2 in the 
External solution to distinguish from contaminating leak currents. The recordings were obtained 
using an Axopatch amplifier and Axon 8.1 software (Axon Instruments, Union City, CA). Data 
were analyzed and graphed using Clampfit 9.2 (Molecular Devices, Sunnyvale, CA) and Excel 
software (Microsoft, Albuquerque, NM). 
 
E) Statistical Analysis 
 
All current values corresponding to -95mV in each ramps were obtained using Clampfit 
9.2 (Molecular Devices, Sunnyvale, CA) and transferred to Excel software (Microsoft, 
Albuquerque, NM). The first few data points of the current versus time plot were averaged to 
obtain the Basal current. The agonist-induced currents were obtained by averaging several 
current values that appear immediately after the slope of the ramp current started to change. 
Similarly, the data points after Barium block were averaged. Barium-sensitive basal and agonist-
induced currents were calculated by subtracting the current remaining after Barium block from 
basal and agonist-induced currents, determined as described above. These values were 
normalized to the membrane capacitance (pF) which correlates with the size of the cells. In the 
statistic analysis, basal and agonist-induced currents from each recording were again averaged. 
Error bars in the figures represent standard error. The standard deviations for each data set were 
divided by the square root of the number of recordings to get the standard errors. The t test was 
used to assess statistical significance (* indicates p≤ 0.01, ** indicate p≤0.005, *** indicate 
p≤0.001). 
  
 
 
RESULTS 
 
Application of GTP induces High GIRK activities in the presence of mGluR2. 
As described in the Materials and Methods, a stable HEK cell line that expresses GIRK 1 
and 4 was transiently transfected with mGluR2. Figure 1A shows a Western blot analysis GIRK1 
levels in various clones of HEK/GIRK cells, whereas Figure 1B shows a Western blot analysis of 
mGluR2 levels in HEK/GIRK/mGluR2 cells, under different conditions of transient transfection. 
Both types of cells, HEK/GIRK and HEK/GIRK/mGluR2, were subjected to whole-cell patch 
clamp recordings. Different concentrations of GTP were added to the internal solution to 
stimulate GIRK activity. A 500 milisecond-long voltage ramp from -100mV to 100mV was 
applied to the cell at 3 second intervals, and the magnitude of the hyperpolarization-induced 
currents (at -95 mV) was plotted as a function of time (Figure 2A). The GIRK current increased 
as GTP entered the cytoplasm but it also desensitized. At the end of all recordings, 3 mM Barium 
Chloride was applied to make sure that the data collected came from the Barium-sensitive GIRK 
channel. Figure 2B shows a summary of GTP-induced GIRK currents in HEK/GIRK cells and 
HEK/GIRK/mGluR2 cells. In the cells that express mGluR2, higher concentrations of GTP 
induced greater GIRK activity. Notably, responses to 100 µM GTP in HEK/GIRK/mGluR2 cells 
were significantly greater than ones in the HEK/GIRK cells. This observation suggested that the 
presence of receptors causes changes in the behavior of G proteins that, in turn, influence the 
activity of GIRK. 
GTPγS-induced GIRK current is greater than Glutamate-induced current. 
The difference between GTPγS-induced and Glutamate-induced GIRK activities was 
examined. Both cell types, HEK/GIRK and HEK/GIRK/mGluR2 were subjected to whole-cell 
patch clamp recordings. In order to make sure GIRK currents were maximally stimulated in 
 every recordings, we measured the activities of GIRK upon exposure to different concentrations 
of Glutamate (Figure 3A). The recordings displayed higher peak currents as we applied higher 
concentrations of Glutamate, and there was no further increase when the concentration exceeded 
100 µM. Figure 3B shows the hill plot that fits the data shown in panel A. 
The GIRK currents responded to both GTPγS and Glutamate as expected. The time-
course traces are shown in Figure 3C. Upon exposure to 100 µM GTPγS, the GIRK activities in 
HEK/GIRK and HEK/GIRK/mGluR2 cells increased to a similar extent. The current increased to 
36-42 pA/pF in HEK/GIRK cells and to 30-38 pA/pF in HEK/GIRK/mGluR2 cells (Figure 3D). 
In HEK/GIRK cells 100 µM Glutamate failed to induce higher GIRK activity than basal level 
due to the absence of mGluR2. In the presence of mGluR2 GIRK currents clearly responded to 
100 µM Glutamate. The currents increased from 8-10 pA/pF to 18-23 pA/pF.  
The GIRK response to Glutamate was significantly lower than the ones induced by 
GTPγS in HEK/GIRK/mGluR2 cells. This observation is consistent with previous studies which 
have suggested that GPCRs, G proteins and ion channels exist as dynamically assembled 
macromolecular complexes that localize into discrete membrane compartments, rather than 
existing as individual proteins freely floating in a homogeneous sea of membrane phospholipids 
(Doupnik, 2008) (See Discussion). 
In the presence of mGluR2, GTP-induced GIRK current displays greater and faster 
desensitization.  
To further characterize mGluR2 influences on GIRK currents, both cell types 
(HEK/GIRK and HEK/GIRK/mGluR2) were again characterized using the whole-cell patch 
clamp technique) Desensitization kinetics were characterized following application of 100µM 
GTP. The time course was plotted for each recordings using the same method described above. 
The current value at steady state (point B in Figure 4A) was divided by the current value at the 
peak (point A in Figure 4A) and the calculated value was subtracted from 1 and multiplied by 
100 to get the %Inhibition plotted in the ordinate. %Inhibition indicates the percentage of the 
peak current that was inhibited during desensitization. 
 The GTP-induced GIRK displayed greater desensitization in the presence of the receptor. 
The current desensitized 35-55 % of its peak current in HEK/GIRK cells but, in 
HEK/GIRK/mGluR2 cells, the degree of desensitization was 64-66 % (Figure 4B).  
In addition to %Inhibition, the time it took to reach steady state was also measured to 
characterize desensitization. The values were obtained by subtracting the time value 
corresponding to the peak current (point A) from the time value corresponding to the beginning 
of the steady-state current, following desensitization (point B). The GTP-induced GIRK current 
took 130-150 seconds to completely desensitize in the absence of mGluR2 (Figure 4C). However, 
the presence of receptor in the system significantly reduced this time to 47-60 seconds. 
Desensitization kinetics become greater and faster when the signaling involves greater 
stimulation of mGluR2.  
Figure 4 showed that the presence of mGluR2 in the system allows for desensitization to 
be greater and faster. This observation motivated us to see whether activating less receptors 
would induce less and slower desensitization. If the amount of receptors being activated was the 
key to the changes in kinetics, activating less receptor should give less inhibition over a longer 
time period. HEK/GIRK/mGluR2 cells were subjected to whole-cell patch clamp recordings. 
Distinct mGluR2 levels could be stimulated by using different concentrations of Glutamate. 
Since the EC50 for Glutamate was 43.6 µM (Figure 3B), 25 µM Glutamate was used to activate 
less amount of the receptor. 
The %inhibition increased with a higher concentration of Glutamate. When the currents 
were stimulated with 25 µM Glutamate, the degree of inhibition was 31-35% and it increased to 
47-56% when 100 µM Glutamate was used (Figure 5B). Also, changing the concentration from 
25 µM to 100µM shortened the amount of time it took for GIRK currents to desensitize from 95-
100 to 77-97 seconds (Figure 5C), even though these two data sets are not significantly different 
according to the result from t-test. These observations further strengthened the idea that the 
presence of mGluR2 affects desensitization kinetics of GIRK currents and showed that the effect 
becomes more potent when the signaling involves greater receptor levels. 
Characterization of recovery from desensitization 
 Previous recordings showed that the presence of mGluR2 makes desensitization kinetics 
of GTPγS-induced and GTP-induced GIRK currents resemble the currents induced by Glutamate. 
These observations motivated us to monitor recovery kinetics of Glutamate-induced GIRK 
currents which can later be used for comparison with the recovery kinetics for GTPγS-induced 
and GTP-induced GIRK currents in the HEK/GIRK/mGluR2 cells. Recordings were again 
performed using whole-cell patch clamp with the same methods and protocol.   
As shown in Figure 6A, HEK/GIRK/mGluR2 cells displayed Glutamate-induced GIRK 
currents upon the first exposure to 100uM Glutamate. After the currents desensitized completely, 
Glutamate was washed away and the cells stayed in the external solution for various lengths of 
time. After a certain period of time, 100 µM Glutamate was again applied to stimulate the second 
Glutamate-induced GIRK currents. Increasing time intervals for the second application following 
the first exposure to Glutamate gave increasingly greater currents (Figure 6B). The time-
dependent recovery of Glutamate-induced GIRK currents shows it takes about 3 minutes to 
recover 53% and 4 minutes to recover fully from the previous exposure to Glutamate.  
In the presence of mGluR2, GTPγS-induced GIRK current displays faster but less 
pronounced desensitization. 
We tested whether the presence of mGluR2 also changes desensitization kinetics of the 
GTPγS-induced currents. Both cell types were again subjected to the whole-cell recording, 
and %inhibition and time values were obtained by the same method described above. In GTP-
induced currents desensitization became greater and faster in the cells expressing mGluR2. 
However, the GTPγS-induced currents showed a different trend. %Inhibition was decreased from 
65-70 (in the absence of receptor) to 45-50 (in the presence of the receptor) (Figure 7B), while 
the time to reach steady-state was dramatically shortened. GTPγS-induced GIRK current took 
285-305 seconds to completely desensitize in the absence of mGluR2, and the mGluR2 in the 
system significantly reduced the time to 95-135 seconds (Figure 7C).  
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Figure 1. Western blot analysis of GIRK1 and mGluR2 levels in HEK/GIRK and 
HEK/GIRK/mGluR2 cells, respectively. 
A. Western blot analysis GIRK1 levels in various antibiotic-resistant clones of HEK-293 cells, stably 
transfected with GIRK1+GIRK4. Probing of the upper part of the same membrane for N-cadherin served 
as an internal loading control. Numbers on the top indicate clone IDs. B.  Western blot analysis of 
mGluR2 levels under different conditions of transient transfection of mGluR2 in HEK/GIRK cells. The 
lower part of the same membrane was probed for GIRK1. 
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Figure  2. Effect of GTP in GIRK currents in HEK/GIRK cells and HEK/GIRK/mGluR2 cells 
A. Representative time course of GIRK activity caused by 100 µM GTP in a HEK/GIRK/mGluR2 cell 
obtained by whole-cell patch clamp. A 500 milisecond-long voltage ramp from -100mV to 100mV was 
applied to the cell at 3 second intervals, and the magnitudes of the hyperpolarization-induced currents (at 
-95 mV) divided by membrane capacitances (pF) were plotted as a function of time. At the end of each 
recording, the GIRK currents were completely abolished by 3 mM Barium Chloride. B. Summary of 
Barium-sensitive, basal and GTP-induced currents in HEK/GIRK and HEK/GIRK/mGluR2 cells, 
calculated as described under MATERIAS AND METHODS.  
  
 
 
HEK/GIRK Cells HEK/GIRK/mGluR2 Cells
0
5
10
15
20
25
10uM 25uM 50uM 100uM 200uM 400uM
‐p
A
/p
F
Glutamate Concentration
0 100 200 300 400
0
5
10
15
20
 
Kd=43.6 μM
h=2.04
pA
/p
F
Glu(μM)
(A) (B)
(C)
(D)
(3)
(3)
(4)
(7)
(6)
(4)
(11)
(11)
(11)
(6)
‐100mV
+100mV
500 ms
‐95 mV
0
5
10
15
20
25
30
35
40
45
50
Basal GTPγS Glutamate Basal GTPγS Glutamate
‐p
A
/p
F
(17) (22)
*** **
 
  
 
 
 
Figure 3. GTPγS- and Glutamate-induced GIRK currents in HEK/GIRK cells and 
HEK/GIRK/mGluR2 cells 
A. Summary of Glutamate titration data, collected by performing whole-cell patch clamp on 
HEK/GIRK/mGluR2 cells and taking values of the peak currents induced by Glutamate. The values 
collected were divided by membrane capacitances to normalize to the size of each cell. 10 µM GTP was 
added to pipette solution to compensate for dilution of the intracellular GTP. Higher concentrations of 
Glutamate induced greater GIRK responses. B. Hill plot that fits the data shown in panel A. Dissociation 
constant for Glutamate is 43.6 µM, and Hill coefficient is 2. C. Voltage ramp protocol and representative 
time-course traces of GIRK currents. Magnitudes of the hyperpolarization-induced currents (at -95 mV) 
divided by membrane capacitances (pF) were plotted as a function of time. D. Summary of basal currents 
and peak currents induced by 100 µM GTPγS and 100 µM Glutamate in HEK/GIRK cells and 
HEK/GIRK/mGluR2 cells. Degrees of significance are indicated by the number of * labels (see Statistical 
Analysis under MATERIALS AND METHODS). 
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Figure 4. Difference in desensitization kinetics of GTP-induced GIRK current caused by the 
presence of mGluR2 
A. Formula for calculating %Inhibition and the time-course trace. B. Summary of %Inhibition of GTP-
induced GIRK currents in HEK/GIRK and HEK/GIRK/mGluR2 cells. GTP-induced currents displayed 
greater desensitization in the presence of mGluR2. C. Summary of observed lengths of time required for 
desensitization of GTP-induced GIRK currents in HEK/GIRK and HEK/GIRK/mGluR2 cells. The values 
were obtained by subtracting the time value corresponding to the beginning of steady current after 
desensitization (point B) from the time value corresponding to the peak current (point A). The currents 
desensitized faster in the presence of mGluR2. 
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Figure 5. Differences in desensitization kinetics demonstrated by using different concentration of 
Glutamate 
A. Formula for calculating %Inhibition and representative time-course trace of GIRK current induced by 
100 µM Glutamate. The recording was obtained by performing whole cell patch clamp. The method and 
protocol is same as described in Figure 2A. B. Summary of %Inhibition of GIRK currents induced by 25 
µM and 100 µM Glutamate. 100 µM Glutamate induced the current with greater desensitization. C. 
Summary of observed lengths of time required for desensitization of GIRK currents after activation 
induced by 25 µM and 100 µM Glutamate, calculated as described in Figure 4.  
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Figure 6. Time-dependent recovery of Glutamate-induced GIRK current 
A. Representative time course traces of glutamate-induced GIRK currents in HEK/GIRK/mGluR2 cells. 
Traces were obtained by whole-cell patch clamp. Cells were perfused with External solution containing 
100 µM Glutamate a few seconds after recordings were initiated. As soon as Glutamate responses 
completely desensitized, cells were washed with normal External solution. When the currents returned to 
basal level, perfusion was stopped for certain period of time, and subsequently, cells were again exposed 
to 100 µM Glutamate. Depending on the length of time between first and second Glutamate perfusions, 
magnitudes of second peak currents varied. The recoveries of currents were quantified by calculating 
for %Recovery as shown above. %Recovery indicates what percentage of first Glutamate response is 
present in the second response. B. Bar graph illustrating time-dependent recovery of GIRK currents. 
Longer waiting period showed greater currents upon second exposure to 100 µM Glutamate.  
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Figure 7. Difference in desensitization kinetics of GTPγS-induced GIRK current caused by the 
presence of mGluR2 
A. Formula for calculating %Inhibition and representative time-course trace of GIRK current induced by 
100 µM GTPγS. The recording was obtained by performing whole cell patch clamp. The method and 
protocol is same as described in Figure 2A. B. Summary of %Inhibition of GTPγS-induced GIRK 
currents in HEK/GIRK and HEK/GIRK/mGluR2 cells. GTPγS-induced currents displayed greater 
desensitization in the absence of mGluR2. C. Summary of observed lengths of time GTPγS-induced 
GIRK currents takes to desensitize in HEK/GIRK and HEK/GIRK/mGluR2 cells. The values were 
obtained by the same method described in Figure 4. The currents desensitized faster in cells expressing 
mGluR2. 
  
 
 
 
DISCUSSION AND FUTURE DIRECTIONS 
 
The aim of this study was to characterize the effect of mGluR2 in GIRK activity. This 
was achieved by comparing stimulated GIRK activities in the presence of mGluR2 with the 
activities in the absence of the receptor. The experimental system without mGluR2 was provided 
by the HEK293 cell line (HEK/GIRK cells) that stably expresses GIRK1 and GIRK4, and this 
cell line was then transiently transfected to include mGluR2 into this signaling system 
(HEK/GIRK/mGluR2 cells). Although it is well known that the amount of the protein expression 
is not consistent with each transient transfection, our data obtained from HEK/GIRK/mGluR2 
transient transfections were quite stable with relatively tight error bars.  
Our study shows that intracellular application of GTP (in the absence of extracellular 
agonist) stimulates GIRK currents. Initially, the preliminary result was obtained unintentionally 
during the process of creating HEK/GIRK/mGluR2 stable cell line. After making the 
HEK/GIRK stable cell line, we transiently transfected it with the mGluR2 and tested whether the 
GIRK channel responded to Glutamate using whole-cell patch clamp recordings. Although 
western blots confirmed the presence of mGluR2 in the cells (see Figure 1B), results from patch-
clamp experiments were negative in yielding Glutamate-induced currents. In fact, the pipette 
solution did not contain GTP and, as it entered the cytoplasm, it was diluting the endogenous 
GTP concentration which needs to be kept high enough for G protein activation to open the 
GIRK channel. We next added 100 uM GTP into the internal solution to support G protein 
activation. The high GTP concentration in the pipette induced a large Barium-sensitive GIRK 
current even before the cells were perfused with Glutamate (Figure 2A). Interestingly, the GTP 
effect was significantly smaller in HEK/GIRK than in HEK/GIRK/mGluR2 cells (Figure 2B). To 
 our knowledge, GTP acts on the G proteins which upon activation open GIRK channel. Yet, the 
exact mechanism by which GTP activates G proteins in the absence of mGluR2 agonist and the 
reason why it exerts a greater effect in the presence of mGluR2 are not clear. One possibility is 
that the molecular interactions between the basally active mGluR2 and G proteins are somehow 
causing structural changes of the G proteins which, in turn, increase their affinity to GTP. One 
experiment that will further test this idea will be to try an inverse-agonist of mGluR2, such as 
LY34, aiming to negate the effect of mGluR2 in the GTP-induced GIRK activation in 
HEK/GIRK/mGluR2 cells. If higher GTP-induced current is in fact mediated via a higher 
mGluR2 activity, simultaneous application of the extracellular LY34 with intracellular GTP 
should attenuate the mGluR2 effect yielding a lower current density, as if the experiments were 
performed in the absence of the receptor.      
The extracellular glutamate can only activate Gi/o proteins that are coupled to the 
mGluR2, unlike GTPγS that can non-specifically activate all G proteins in the cell. In the 
HEK/GIRK/mGluR2 cells the GIRK response to glutamate was significantly lower than the 
response to GTPγS (Figure 3D). This result suggests that pool of G proteins able to activate the 
GIRK current (Gi/o) extends beyond the pool of G proteins associated with the mGluR2. This 
result was somewhat surprising because the transient transfection caused over-expression of 
mGluR2, but there were still excess amount of Gi/o proteins that were not associated with the 
receptor. The result shown in Figure 2 also suggested that the interaction between mGluR2 and 
the Gi/o protein exists even in the absence of the mGluR2 agonist. The studies done by Mirshahi 
et al. in 2002 showed that the basal GIRK activity, in addition to the stimulated GIRK activity, is 
also supported by the interaction between Gβγ subunit and GIRK (Mirshahi et al., 2002).  These 
findings together strengthen the idea that GPCRs, G proteins and ion channels exist as 
dynamically assembled macromolecular complexes that localize into discrete membrane 
microdomains (Doupnik, 2008).  
While we were recording data as those shown in Figure 2, we often recognized in the 
currents we obtained another distinguishable feature caused by the presence of mGluR2. Both 
cell types were first subjected to the whole-cell patch clamp recordings, showing that GIRK 
current induced by 100 µM GTP displayed greater and faster desensitization kinetics in the 
presence of mGluR2 (Figure 4). Here again, we demonstrate that mGluR2 affects the behavior of 
 G proteins even in the absence of the agonist. Moreover, the data suggest that the role of the 
receptor is not only to transmit the extracellular signals to the cytoplasm, but also to make the 
signals briefer, serving as a limiting agent that prevents prolonged activation of the downstream 
pathway. The observed effect of mGluR2 in desensitization kinetics of GIRK current motivated 
us to test whether activating less receptor through signaling would give smaller and slower 
desensitization. The idea behind this experiment was that, if the amount of receptors being 
activated were the key to the changes in kinetics, activating less receptor should give less 
inhibition over a longer period of time. We activated less amount of the mGluR2 by using 25 µM 
extracellular Glutamate which is less than EC50 shown in Figure 3B. Our data suggest that 
involving more receptors in the signaling (i.e. with 100 µM Glutamate) would result in a greater 
and quicker desensitization (Figure 5). We confirmed that the changes in desensitization kinetics 
were indeed caused by the amount of mGluR2 that was activated. However, the mechanism by 
which the mGluR2 affects desensitization kinetics of GIRK current remains unclear. It is also not 
clear what causes the desensitization in the absence of mGluR2. It is possible that the GTP in the 
pipette solution was activating Gq protein pathway in addition to Gi pathway, which, in turn, 
would activate phospholipase C (PLC). PLC hydrolyzes phosphatidylinositol-4,5- bisphosphate 
(PIP2) that supports the GIRK activity. Previous studies showed that the Gq-mediated PIP2 
depletion contributed to GIRK current inhibition (Keselman at el, 2007). Although the data 
collected by Keselman at el. show greater and quicker desensitization, we should account for the 
fact that GTP is not as potent as acetylcholine on muscarinic receptors in Gq activation. 
Moreover, we showed that GTP gives a greater effect when the G proteins are associated with 
the receptors. The amount of Gq proteins associated with the receptors is likely to have been 
much less than the amount of Gi proteins associated with the over-expressed mGluR2. The idea 
that the smaller and slower desensitization of GIRK current in the absence of mGluR2 is carried 
out by Gq-mediated PIP2 hydrolysis could be tested by using PLC blocker, such as U73122, that 
blocks the Gq pathway. If PLC involvement were true, the current inhibition would be much less 
or not happen at all in the presence of U73122. 
We were motivated to characterize the recovery kinetics of the Glutamate-induced GIRK 
current. Waiting longer after the first exposure to 100 µM glutamate resulted in greater recovery 
of current upon a second exposure, and it took 4 minutes to fully recover (Figure 6). It is still not 
 clear whether this characteristic is due to the mGluR2 or it is an intrinsic property of the G 
protein. To clarify this, the time-dependent recovery kinetics that we characterized should be 
compared with the recovery kinetics from GTPγS- or GTP-induced GIRK currents, experiments 
that is not clear how to do using the whole-cell mode of the patch clamp technique. 
We also examined how desensitization kinetics of GTPγS-induced GIRK currents 
changed in the presence of mGluR2. Contrary to our expectation, the GTPγS-induced current 
desensitized less in the presence of mGluR2, although the rate at which the current desensitized 
became much faster as expected (Figure 7). The different outcomes should be due to the 
difference between GTP and GTPγS because those were the only variables between the two 
experiments. GTP can be hydrolyzed by the intrinsic GTPase activity of the Gα subunits, thus 
allowing the G protein cycle to take place in a GPCR-dependent manner.  In contrast GTPγS 
once it binds, it cannot be hydrolyzed therefore not allowing for G protein cycling.  We surmise 
that the presence of G protein cycling limits the time G proteins are activated to cause channel 
activation thus producing less current and this accounts for one aspect of desensitization, namely 
the faster component that is Gi-dependent, since it is only Gi proteins that activate GIRK 
currents.  A second slower component of desensitization would result from activation of PLC as 
discussed above, hydrolyzing PIP2 and limiting the time GIRK could be maintained open.  Thus 
we have two ways in which we control current level: one through stimulating GIRK channels via 
a Gi-coupled mechanism that due to the cycling of G proteins shows a fast component of 
desensitization and another mechanism which manifests itself as a slower mechanism of 
desensitization by hydrolyzing PIP2 and limiting the ability of the channel to stay open.  Since 
the two mechanisms of controlling GIRK activity, namely the stimulatory Gi (with its relatively 
faster desensitization) and the inhibitory Gq (with its relatively slower desensitization), work in 
opposite ways, removing the Gi cycling with GTPγS would cause the stimulation without the fast 
desensitization and now allow the second mechanism to inhibit without contribution from the Gi 
cycling mechanism.  This may yield a lower level of inhibition and somehow affect the kinetics 
of the Gq inhibition to manifest themselves faster.  Another possibility is that the greater potency 
of GTPγS, compared to GTP, might have activated unknown factors that counteract 
desensitization.  
 Our results provide important information about the interactions of mGluR2 with G 
proteins and how the receptor influences GIRK activation and desensitization that are likely to 
stimulate additional studies in the laboratory to further investigate the mechanisms by which the 
GPCR controls activation and desensitization of GIRK currents. In addition, these studies have 
contributed to a better picture of how the molecules (GPCRs, G proteins, ion channels) are 
distributed in the plasma membrane likely forming preferential macromolecular complexes –that 
represent only a fraction of the overall activatable channel current. 
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